ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 887

Critical Role of the Cholinergic System Involvement in Osteoarthritis

Alice Courties1, Ariane Do 1, Sarah Leite 2, Audrey Pigenet 2, Morgane Belle 3, Geoffroy Nourissat 4, Alain Sautet 5, Alain Chedotal 3, Uwe Maskos 6, Francis Berenbaum 7 and Jérémie Sellam 1, 1Service de Rhumatologie, AP-HP Hôpital Saint-Antoine, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 2Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France, Paris, France, 3Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France, Paris, France, 4Chirurgie orthopédique, Clinique Maussins, Groupe Ramsay générale de santé, 67 rue de Romainville, 75019, Paris, Paris, France, 5Chirurgie orthopédique, AP-HP Hôpital Saint-Antoine, Paris, Paris, France, 6Unité de neurobiologie intégrative des systèmes cholinergiques, CNRS UMR 3571, Institut Pasteur, Paris, Paris, France, 7Sorbonne Université-Inserm CDR Saint-Antoine, AP-HP, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Inflammation, nicotinic receptor and cholinergic, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S105: Osteoarthritis & Joint Biology – Basic Science (886–891)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The efferent vagus nerve can regulate inflammation via its principal neurotransmitter acetylcholine (ACh), a concept referred as the ‘cholinergic anti-inflammatory pathway’. ACh interacts with members of the nicotinic acetylcholine receptor (Chrna) family, in particular with the alpha7 subunit (Chrna7), which is expressed not only by neurons but also by other cells involved in inflammation.

We aimed to decipher the roles of the non-neuronal and neuronal cholinergic systems in osteoarthritis (OA).

Methods: To explore the presence of neuronal cholinergic fibers in the joints, we used a whole joint immunolabeling protocol after 3Disco clearing. We evaluated the coexpression of peripherin (nerve marker) and choline acetyltransferase (cholinergic marker) in human bone-cartilage samples, from OA patients undergoing knee arthroplasty.

To explore the role of the non-neuronal cholinergic pathway, primary cultures of human OA chondrocytes and of WT and KO Chrna7-/- murine osteoblasts (OB) and chondrocytes were performed. The expressions of the molecular partners of Ach metabolism and of the cholinergic nicotinic receptors were assessed. In vitro, WT and Chrna7-/- chondrocytes and OB were treated with IL1b for 24h. In order to study the role of nicotinic receptors in cell activation, chondrocytes and OB were pretreated with nicotine at 1; 10 or 100 μM.  We quantified the production of interleukin-6 (IL6) and metalloproteinase (MMP) along with RANK-ligand for OB by ELISA.

To induce OA, medial meniscus destabilization (DMM) of the knee was performed on 12-week-old WT and Chrna7 – / – mice and histological OARSI scoring was compared after 8 weeks between both genotypes.  

Results: Cholinergic fibers were present in subchondral bone of all 3 OA joints explants analyzed coming from 3 different patients (Fig 1). Human OA and murine chondrocytes as well as murine OB express the whole machinery needed for the synthesis, transport and degradation of Ach. All these cells express nicotinic subunits a 4, 5, 6, 7 and β4. IL1β stimulation induced a significant increased production of IL6 and MMPs by WT and Chrna7-/- chondrocytes. Nicotine pretreatment counteracted this effect (decrease of 65% for IL6, 64% for MMP3 with nicotine 10µM, n=5; p< 0.05). Conversely to what happened in WT, nicotine had no effect on Chrna7-/- chondrocytes supporting a predominant role of this receptor in chondrocyte activation. In OB, stimulation of nicotinic receptors decreased the production of IL6, MMP3 and RANK-L induced by IL1β in the same manner in WT and Chrna7-/- OB, meaning that other subunits than a7 are involved in OB activation. After DMM, Chrna7 -/- mice displayed significantly more OA lesions than their WT counterparts with a mean±SD OARSI score of 8.9±0.82 for Chrna7 -/- and 6.1±0.6 for WT (Fig 2).

Conclusion: Neuronal and non-neuronal cholinergic systems are present in murine and human joints. The activation of nicotinic receptors displays anti-inflammatory, anti-catabolic and antiresorptive properties on bone and cartilage. In chondrocytes  this protective effect is mediated by the Chrna7 suggesting that activating the cholinergic system could be a new therapeutic target in OA.

Figure 1: A: Osteoarthritic human bone and cartilage sample before and after 3DISCO clearing protocol, B and C: 3D in toto immunofluorescence of peripherin -nerve marker- in green and of ChAT -cholinergic nerve fiber- in red with colocalization of their expressions.

Figure 2: Chrna7 gene deletion is associated with more severe post-traumatic murine OA Left : OARSI score of the sum of femoral condyle and tibial plateau -0-12, 12 being the worst- between WT -n=9- and Chrna7 -/- -n=7- mice 8 weeks after the DMM,*p<0.05; Right : Representative SafraninO/fast green stained sections of the right knee 8 weeks after DMM in WT and Chnra7 -/- mice


Disclosure: A. Courties, None; A. Do, None; S. Leite, None; A. Pigenet, None; M. Belle, None; G. Nourissat, None; A. Sautet, None; A. Chedotal, None; U. Maskos, None; F. Berenbaum, 4P Pharma, 2; J. Sellam, Janssen, 8.

To cite this abstract in AMA style:

Courties A, Do A, Leite S, Pigenet A, Belle M, Nourissat G, Sautet A, Chedotal A, Maskos U, Berenbaum F, Sellam J. Critical Role of the Cholinergic System Involvement in Osteoarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/critical-role-of-the-cholinergic-system-involvement-in-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/critical-role-of-the-cholinergic-system-involvement-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology